The emergence of immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines has underscored the importance of understanding tumor immunobiology at a systems level. Immuno-oncology research increasingly relies on large-scale, multi-modal datasets, including genomics, transcriptomics, proteomics, and spatial data, to characterize tumor environments. Bioinformatics and computational analytics enable the extraction of actionable insights from […]
The emergence of immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines has underscored the importance of understanding tumor immunobiology at a systems level. Immuno-oncology research increasingly relies on
G Protein-Coupled Receptors (GPCRs) in the Immune System The human genome encodes approximately 800 G protein–coupled receptors (GPCRs), representing a structurally conserved yet functionally diverse superfamily that underpins
Fibrosis is a final common pathological end-point of chronic injury in multiple organs, characterized by persistent myofibroblast activation, excessive extracellular matrix (ECM) deposition, and progressive organ dysfunction. Although
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity globally. According to the Global Burden of Disease studies, COPD is among the top three causes
Abstract DNA-damaging chemotherapies remain foundational in cancer treatment and are increasingly recognized as potent modulators of anti-tumor immunity. Genotoxic stress activates innate immune sensing pathways, most prominently the
T cells play a central role in immune surveillance by recognizing and eliminating malignant cells, thereby preventing cancer initiation and progression. Through antigen-specific cytotoxic activity and the production of
Introduction Antibody–drug conjugates (ADCs) have emerged as a transformative class of targeted cancer therapies by combining the specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. Over the
The development of epigenetic therapeutics marks a fundamental shift in modern drug discovery, moving beyond permanent genetic alterations to target reversible regulatory modifications on DNA and histones. DNA methylation–targeting
Introduction The development of optogenetics-based gene therapies for inherited retinal diseases represents a transformative strategy for vision restoration but presents unique challenges in pharmaceutical development. One of the most
Download the full article (PDF) MarinBio Blog Diabetes / Liver Cirrhosis & Cancer / Obesity / Dementia This blog will emphasize lifestyle diseases and their considerable interrelatedness among various disorders.
